3B Blackbio Dx

₹1,276As of Sun 8 Nov 2026, 12:00 UTC

NSE:3BBLACKBIOHealthcare

Country India

PE (Fwd) 15.96

TSR 10Y CAGR —

Div yield 0.39%

ROE —

Biotechnology

Beta (5Y) 0.48

PE TTM 18.24

TSR TTM —

Mkt cap ₹11.06B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹1,427

11.84%

(47.90%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

1.419

Revenue₹B

—

—

—

—

—

0.875

0.621

0.744

0.965

1.419

1.515

12.84%

12.84%

67

47.11

Revenue growth%

—

—

—

—

—

—

(29.11)

19.89

29.64

47.11

6.75

24.76

—

80

74.01

Gross margin%

—

—

—

—

—

63.64

71.14

70.25

72.98

74.01

74.25

71.14

71.14

50

44.44

Operating margin%

—

—

—

—

—

49.49

46.65

43.55

51.17

44.44

44.35

46.65

46.65

95

42.23

Net margin%

—

—

—

—

—

36.78

41.79

43.14

49.44

42.23

42.38

42.23

42.23

90

18.24

P/E ratio (avg)x

—

—

—

—

—

—

—

—

—

—

17.03

—

—

—

17.34

EV/EBITx

—

—

—

—

—

—

—

—

—

—

16.27

—

—

—

—

FCF yield (avg)%

—

—

—

—

—

—

—

—

—

—

—

—

—

93

—

FCF margin%

—

—

—

—

—

—

—

—

—

—

—

—

—

96

—

FCF / Net incomex

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

ROIC%

—

—

—

—

—

—

—

—

—

—

—

—

—

96

—

Return on equity%

—

—

—

—

—

—

—

—

—

—

—

—

—

96

—

Return on assets%

—

—

—

—

—

—

—

—

—

—

—

—

—

97

69.94

EPS₹

—

—

—

—

—

42.98

30.28

37.46

55.66

69.94

74.94

12.95%

12.95%

—

25.66

EPS growth%

—

—

—

—

—

—

(29.55)

23.74

48.56

25.66

7.14

24.70

—

—

—

Bookvalue per sh₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

FCF per share₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

5.00

Dividend per sh₹

—

—

—

—

—

2.50

2.50

3.00

4.00

5.00

5.36

18.92%

18.92%

—

0.39

Div yield (avg)%

—

—

—

—

—

—

—

—

—

—

0.42

—

—

—

7.15

Payout ratio%

—

—

—

—

—

5.82

8.26

8.01

7.19

7.15

7.16

7.19

7.19

—

8.568

Shares (diluted)M

—

—

—

—

—

7.492

8.566

8.568

8.568

8.568

◌8.568

3.41%

3.41%

92

—

Buyback yield%

—

—

—

—

—

—

(14.34)

(0.02)

—

—

◌—

(0.01)

—

92

—

D/E ratiox

—

—

—

—

—

—

—

—

—

—

—

—

—

81

10.93

Enterprise value₹B

—

—

—

—

—

—

—

—

—

—

10.93

—

—

69

—

LT debt₹M

—

—

—

—

—

—

—

—

—

—

—

—

—

13

Peers (US$117.9M)

Cap (US$)

PE

Dishman Carbogen Amcis…

261.4M

151.8x

Panacea Biotec Limited

224.3M

—

Haleos Labs Limited

45.23M

26.89x

Helixmith Co., Ltd

117.6M

—

Capital

TTM

5Y

10Y

Leveragex

—

—

—

EBIT/Intx

266.0

266.0

266.0

Own earn%

—

—

—

Sh yield%

0.39

(0.01)

(0.01)

Owners

Insiders/Inst%

47.61

3.81

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

3/4

EPS growth years

3/4

Dividend streakyrs

0

Op margin range%

44–51

$1 testx

—

Incr. ROIC%

—

3B Blackbio Dx Limited manufactures and sells molecular diagnostic kits in India.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹1.419B

12.84%

1.00×

Cost of revenue

₹368.8M

3.75%

0.71×

Operating expenses

₹419.8M

35.67%

2.09×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

-

Return on capital

n/m

-

Spread over hurdle

n/m

-